{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:28:34Z","timestamp":1791350914480,"version":"4.3.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.smrv.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T07:41:32Z","timestamp":1114587692000},"page":"185-200","source":"Crossref","is-referenced-by-count":192,"title":["Excessive daytime sleepiness in parkinsonism"],"prefix":"10.1016","volume":"9","author":[{"given":"Isabelle","family":"Arnulf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2005.01.001_bib1","series-title":"An essay on the shaking palsy","author":"Parkinson","year":"1817"},{"key":"10.1016\/j.smrv.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","article-title":"The night-time problems of Parkinson's disease","volume":"11","author":"Lees","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2005.01.001_bib3","first-page":"125","article-title":"Troubles du sommeil dans la maladie de Steele-Richardson [in French]","volume":"132","author":"Leygonie","year":"1976","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.smrv.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.48.4.1094","article-title":"REM sleep behavior disorders in multiple system atrophy","volume":"48","author":"Plazzi","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1212\/WNL.51.2.363","article-title":"REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease","volume":"51","author":"Boeve","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO;2-6","article-title":"Waking up to sleep episodes in Parkinson's disease","volume":"15","author":"Olanow","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.52.9.1908","article-title":"Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole","volume":"52","author":"Frucht","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/1531-8257(200007)15:4<601::AID-MDS1003>3.0.CO;2-Q","article-title":"Sleep episodes in Parkinson's disease: a wake-up call","volume":"15","author":"Frucht","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.58.3.341","article-title":"Emerging views of dopamine in modulating sleep\/wake state from an unlikely source: PD","volume":"58","author":"Rye","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib10","first-page":"1313","article-title":"Pharmacologie, somnolence diurne anormale, \u2018attaques de sommeil\u2019 et m\u00e9dicaments antiparkinsoniens","volume":"157","author":"Rascol","year":"2001","journal-title":"Rev Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.smrv.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1126\/science.282.5391.1075","article-title":"Genetic classification of primary neurodegenerative disease","volume":"282","author":"Hardy","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.smrv.2005.01.001_bib13","first-page":"55","article-title":"The pathology of Parkinson's disease","volume":"86","author":"Jellinger","year":"2001","journal-title":"Adv Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","article-title":"Low levels of ventricular CSF orexin\/hypocretin in advanced PD","volume":"61","author":"Drouot","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2869.2000.00177.x","article-title":"Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth Sleepiness Scale: failure of the MSLT as a gold standard","volume":"9","author":"Johns","year":"2000","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.58.10.1544","article-title":"Development of daytime somnolence over time in Parkinson's disease","volume":"58","author":"Gjerstad","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.58.3.465","article-title":"Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls","volume":"58","author":"Tan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002826-200105000-00013","article-title":"Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study","volume":"24","author":"Montastruc","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","article-title":"Excessive daytime sleepiness and sudden-onset sleep in Parkinson Disease. A survey by the Canadian Movement Disorder Group","volume":"287","author":"Hobson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.smrv.2005.01.001_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s004140050131","article-title":"Falling asleep while driving: are drivers aware of prior sleepiness ?","volume":"111","author":"Reyner","year":"1998","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.smrv.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/mds.20163","article-title":"Predictors of sudden onset of sleep in Parkinson's disease","volume":"19","author":"Korner","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.10020","article-title":"Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study","volume":"17","author":"M\u00f6ller","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0140-6736(00)02118-8","article-title":"Sleep attacks (sleep episodes) with pergolide","volume":"355","author":"Schapira","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(00)02119-X","article-title":"Sleep attacks and Parkinson's disease treatment","volume":"355","author":"Ferreira","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2005.01.001_bib27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.58.3.462","article-title":"Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD","volume":"58","author":"Ulivelli","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.61.1.97","article-title":"Predictors of impaired daytime sleep and wakefulness in patients with Parkinson's disease treated with older (ergot) vs. newer (nonergot) dopamine agonist","volume":"61","author":"Razmy","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2869.2000.00201.x","article-title":"FAST TRACK: daytime sleepiness in Parkinson's disease","volume":"9","author":"Rye","year":"2000","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","article-title":"Parkinson's disease and sleepiness: an integral part of PD","volume":"58","author":"Arnulf","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib31","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s004150170148","article-title":"Successful treatment of excessive daytime sleepiness in Parkinson's disease","volume":"248","author":"Happe","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N","article-title":"Pramipexole-induced somnolence and episodes of daytime sleep","volume":"4","author":"Hauser","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.1083","article-title":"Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings","volume":"16","author":"Tracik","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000058905.71369.97","article-title":"Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness","volume":"60","author":"Merino-Andreu","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1212\/WNL.55.2.281","article-title":"Hallucinations, REM sleep and Parkinson's disease","volume":"55","author":"Arnulf","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib36","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.53.8.1868","article-title":"Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset","volume":"53","author":"Rye","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/mds.10439","article-title":"Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's Disease","volume":"18","author":"Nomura","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1212\/01.WNL.0000038351.32678.4A","article-title":"Hallucinations and sleep-wake cycle in PD: A 24-hour continuous polysomnographic study","volume":"59","author":"Manni","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.57.8.1392","article-title":"Daytime sleepiness and other sleep disorders in Parkinson's disease","volume":"57","author":"Ondo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mds.10417","article-title":"Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease","volume":"18","author":"Paus","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1389-9457(03)00105-9","article-title":"Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS)","volume":"4","author":"Kumar","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2005.01.001_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archneur.59.6.986","article-title":"Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson's disease","volume":"59","author":"O'Suilleabhain","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s007020170098","article-title":"A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy","volume":"108","author":"Pal","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.smrv.2005.01.001_bib44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mds.20134","article-title":"Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease","volume":"19","author":"Paus","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/sleep\/27.4.733","article-title":"Association of daytime sleepiness with COMT polymorphism in patients with Parkinson's disease: a pilot study","volume":"27","author":"Frauscher","year":"2004","journal-title":"Sleep"},{"issue":"10 suppl","key":"10.1016\/j.smrv.2005.01.001_bib46","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.smrv.2005.01.001_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/smrv.2002.0229","article-title":"Parkinson's disease and sleep","volume":"7","author":"Garcia-Borreguero","year":"2003","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2005.01.001_bib48","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.10193","article-title":"Excessive daytime sleepiness in de novo and treated Parkinson's disease","volume":"17","author":"Fabbrini","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u2018Mini-mental state\u2019. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2005.01.001_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.smrv.2005.01.001_bib52","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.58.3.498","article-title":"Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness","volume":"58","author":"Overeem","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib54","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.001_bib55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1212\/WNL.54.1.274","article-title":"Falling asleep at the wheel: motor vehicle mishaps in patients taking pramipexole and ropinirole [Letter]","volume":"54","author":"Olanow","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1472-8206.2003.00122.x","article-title":"Piribedil-induced sleep attacks in Parkinson's disease","volume":"17","author":"Tan","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.smrv.2005.01.001_bib57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jnnp.42.5.458","article-title":"Dopamine receptors and sleep induction in man","volume":"42","author":"Bassi","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.001_bib58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archneur.1992.00530350045017","article-title":"Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease","volume":"49","author":"Gasser","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s004150170188","article-title":"Levodopa monotherapy can induce \u2018sleep attacks\u2019 in Parkinson's disease patients","volume":"248","author":"Ferreira","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib60","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/WNL.61.7.1008","article-title":"L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment","volume":"61","author":"Garcia-Borreguero","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib61","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneur.61.7.1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial","volume":"61","author":"Holloway","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.278.2.125","article-title":"Safety and efficacy of pramipexole in early Parkinson's disease. A randomized dose-ranging study","volume":"278","author":"Parkinson Study Group","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.smrv.2005.01.001_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1389-9457(03)00058-3","article-title":"Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists","volume":"4","author":"Roth","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2005.01.001_bib64","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/bmj.324.7352.1483","article-title":"Sleep attacks in patients taking dopamine agonists: review","volume":"324","author":"Homann","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.smrv.2005.01.001_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002826-199901000-00004","article-title":"L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers","volume":"22","author":"Andreu","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2005.01.001_bib66","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1212\/WNL.58.3.460","article-title":"Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers","volume":"58","author":"Ferreira","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib67","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","author":"Nishino","year":"1998","journal-title":"Sleep Res Online"},{"key":"10.1016\/j.smrv.2005.01.001_bib68","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.93.24.14128","article-title":"Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat","volume":"93","author":"Lin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.smrv.2005.01.001_bib69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00181955","article-title":"Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat","volume":"95","author":"Monti","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.smrv.2005.01.001_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(73)90830-5","article-title":"The effects of lesions of cathecolamin-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat","volume":"58","author":"Jones","year":"1973","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/smrv.2000.0116","article-title":"Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons","volume":"4","author":"Lin","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2005.01.001_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-8993(83)91101-0","article-title":"Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat","volume":"273","author":"Miller","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-7091-0643-3_6","article-title":"Animal models of Parkinson's disease in rodents induced by toxins: an update","volume":"65","author":"Hirsch","year":"2003","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.smrv.2005.01.001_bib74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00001756-199501000-00024","article-title":"Selective suppression of type B monoamine oxidase immunoreactivity in the raphe nuclei following MPTP administration in the cat","volume":"6","author":"Lin","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.smrv.2005.01.001_bib75","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0006-8993(90)90880-K","article-title":"A novel effect of MPTP: the selective suppression of paradoxical sleep in cats","volume":"525","author":"Pungor","year":"1990","journal-title":"Brain Res"},{"issue":"suppl","key":"10.1016\/j.smrv.2005.01.001_bib76","first-page":"S18","article-title":"Nocturnal sleep and daytime sleepiness in the MPTP-treated primate","volume":"22","author":"Daley","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.001_bib77","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/j.1460-9568.2004.03694.x","article-title":"Vigilance states in a parkinsonian model, the MPTP mouse","volume":"20","author":"Monaca","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.001_bib78","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.smrv.2005.01.001_bib79","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.smrv.2005.01.001_bib80","first-page":"A332","article-title":"Sleep disturbances in the Rotenone-animal model of Parkinson disease","volume":"26","author":"Garcia-Garcia","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.001_bib81","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/WNL.49.4.999","article-title":"Sleep and quantitative EEG in patients with progressive supranuclear palsy","volume":"49","author":"Montplaisir","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib82","unstructured":"Arnulf I, Merino-Andreu M, Bloch F, Konofal E, Vidailhet M, Cochen V, et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005;28(3):349\u2013354."},{"key":"10.1016\/j.smrv.2005.01.001_bib83","first-page":"1053","article-title":"Excessive daytime sleepiness and low CSF orexin-A\/hypocretin-I levels in a patient with probable progressive supranuclear palsy [in Japanese]","volume":"55","author":"Hattori","year":"2003","journal-title":"No To Shinkei"},{"key":"10.1016\/j.smrv.2005.01.001_bib84","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.72.6.798","article-title":"Sleep disorders and their determinants in multiple system atrophy","volume":"72","author":"Ghorayeb","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.001_bib85","first-page":"6S77","article-title":"Sleep disorders in taupathy and synucleopathy","volume":"159","author":"Arnulf","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib86","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib87","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib88","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1212\/WNL.45.4.709","article-title":"Incidental Lewy body disease in a patient with REM sleep behavior disorder","volume":"45","author":"Uchiyama","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079749","article-title":"Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness","volume":"52","author":"Baumann","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.smrv.2005.01.001_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mds.10639","article-title":"Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus","volume":"19","author":"Hjort","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib91","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(00)02824-5","article-title":"Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group","volume":"356","author":"Iranzo","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2005.01.001_bib92","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1353-8020(00)00035-3","article-title":"Modafinil for the treatment of excessive daytime sleepiness in Parkinson's disease: a case-report","volume":"7","author":"Rabinstein","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib93","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/1531-8257(200011)15:6<1269::AID-MDS1036>3.0.CO;2-R","article-title":"Modafinil treatment of pramipexole-associated somnolence","volume":"15","author":"Hauser","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib94","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"Hogl","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.001_bib95","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2005.01.001_bib96","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.001_bib97","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/jnnp.70.6.812","article-title":"Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease","volume":"70","author":"Arnulf","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.001_bib98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00002826-200405000-00003","article-title":"Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease","volume":"27","author":"Mesnage","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2005.01.001_bib99","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02259133","article-title":"Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis","volume":"88","author":"Fuxe","year":"1992","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00228393","article-title":"The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway","volume":"93","author":"Ueki","year":"1993","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s002210000370","article-title":"Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset","volume":"133","author":"Jenner","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.smrv.2005.01.001_bib102","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00002826-200107000-00003","article-title":"Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: a pilot study","volume":"24","author":"Camicioli","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2005.01.001_bib103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1176\/appi.neuropsych.14.4.461","article-title":"Methylphenidate treats apathy in Parkinson's disease","volume":"14","author":"Chatterjee","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.smrv.2005.01.001_bib104","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.58.8.1154","article-title":"Caffeinated clues and the promise of adenosine A(2A) antagonists in PD","volume":"58","author":"Schwarzschild","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.001_bib105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.10429","article-title":"Sleepiness in Parkinson's disease: a controlled study","volume":"18","author":"Brodsky","year":"2003","journal-title":"Mov Disord"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079205000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079205000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:35:12Z","timestamp":1550226912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079205000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1087079205000031"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2005.01.001","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}